Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma

Jan J Molenaar1, Peter van Sluis, Kathy Boon

  • 1Department of Human Genetics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Insights

Cyclin D1 (CCND1) is overexpressed in some neuroblastomas, suggesting its deregulation contributes to tumor development. Researchers found high CCND1 mRNA and protein levels, with some tumors showing CCND1 gene amplification or rearrangement.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • Cyclin D1 (CCND1) controls cell cycle progression and is often deregulated in cancers.
  • Neuroblastoma typically lacks consistent G1 cell cycle checkpoint aberrations.

Purpose of the Study:

  • To investigate the potential deregulation of cyclin D1 (CCND1) in neuroblastoma.
  • To determine if CCND1 overexpression or genetic alterations play a role in neuroblastoma tumorigenesis.

Main Methods:

  • Serial Analysis of Gene Expression (SAGE) for mRNA profiling.
  • Northern blot analysis for CCND1 expression.
  • Screening for CCND1 gene amplifications and rearrangements.

Main Results:

  • High CCND1 mRNA expression was observed in a subset of neuroblastoma cell lines and tumors (up to 0.3% of total mRNA).
  • Relative CCND1 overexpression was confirmed in 16/23 cell lines and 10/15 tumors, correlating with elevated protein levels.
  • CCND1 gene amplifications were found in 5/202 samples, and a rearrangement in 1/96 tumors.

Conclusions:

  • Relative overexpression of CCND1 occurs in neuroblastoma.
  • Clonal aberrations of CCND1, alongside high expression, suggest its deregulated activity contributes to neuroblastoma development.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...